Livija Šimičević

9PUBLICATIONS
20CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Molecular targetsGene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 28, 2026
Pharmacogenomics of Rivaroxaban: Association of CYP3A4, CYP3A5, CYP2J2, ABCB1, and ABCG2 Variants with Bleeding and Thrombotic Outcomes in Real-World Clinical Practice.

|Apr 27, 2026
ABCG2 Genetic Variability in Drug Exposure and Toxicity: Implications for Clinical Practice.

|Sep 27, 2025
Pharmacogenetics Approach for Personalized Tacrolimus Dosing in Heart Transplantation: A Case Report and Literature Review.

Nives Nikpalj, Jure Samardžić, Nada Božina

|Feb 26, 2025
Association of rs3798220 Polymorphism with Cardiovascular Incidents in Individuals with Elevated Lp(a).

Dunja Leskovar Lemešić, Livija Šimičević, Lana Ganoci

|May 25, 2024
Is CYP2C Haplotype Relevant for Efficacy and Bleeding Risk in Clopidogrel-Treated Patients?

Lana Ganoci, Jozefina Palić, Vladimir Trkulja

|Jan 13, 2023
DPYD genotyping and predicting fluoropyrimidine toxicity: where do we stand?

Lucija Lešnjaković, Lana Ganoci, Ivan Bilić

Pageof 2

Frequent Collaborators

6 joint publications

Lana Ganoci

5 joint publications

Tamara Božina

4 joint publications

Nada Božina

4 joint publications

Vladimir Trkulja